CIAM
CCCC icon

Caitong International Asset Management’s C4 Therapeutics CCCC Stock Holding History

Caitong International Asset Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56K Buy
+592
New +$1.39K ﹤0.01% 1295
2025
Q4 		– Sell
-19,146
Closed -$42.5K – 1932
2025
Q3 		$42.5K Buy
+19,146
New +$46K 0.03% 375
2025
Q1 		– Sell
-15
Closed -$54 – 2202
2024
Q4 		$54 Buy
+15
New +$75 ﹤0.01% 1640

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caitong International Asset Management's CCCC Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in C4 Therapeutics (CCCC) in Q1 2026: 592 shares worth $1.56K. The stake represents ﹤0.01% of the portfolio and ranks #1295 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in CCCC as recently as Q3 2025.

Caitong International Asset Management first reported a position in CCCC in Q4 2024 and has held it in 3 quarters since. The position peaked at $42.5K in Q3 2025. 123 funds tracked by Wall St. Rank hold CCCC as of Q1 2026.

  • Caitong International Asset Management held 592 shares of C4 Therapeutics worth $1.56K as of Q1 2026.
  • C4 Therapeutics was a new Caitong International Asset Management position in Q1 2026.
  • C4 Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1295 holding.
  • Caitong International Asset Management first reported a position in C4 Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Caitong International Asset Management's C4 Therapeutics position peaked at $42.5K in Q3 2025.
  • 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.